Healy D L
Monash University, Department of Obstetrics and Gynaecology, Clayton, Victoria.
Aust N Z J Obstet Gynaecol. 1994 Jun;34(3):357-60. doi: 10.1111/j.1479-828x.1994.tb01089.x.
Anti-progesterone medicines have now been extensively studied for human fertility regulation. The combination of the anti-progesterone Mifepristone with prostaglandin analogues such as Gemeprost and Misoprostol have been used in several European centres for medical abortion. Used before nine weeks gestation, these medicines have similar efficacy to surgical abortion. In addition, administration of progesterone antagonists within five days of unprotected intercourse appear effective in pregnancy prevention. Anti-progesterone medicines are not currently available in Australia. The introduction of progesterone receptor antagonists and modern prostaglandins would save approximately $10,000,000 per year to the Australian Health Budget. Furthermore, the introduction of progesterone receptor antagonists for emergency contraception would have even greater financial and emotional savings for Australian women. In Australia, when known carcinogens can be purchased over the counter, it is surely time for Australians to consider effective emergency contraception bought over the counter.
抗孕激素药物目前已被广泛研究用于人类生育调节。抗孕激素米非司酮与吉美前列素和米索前列醇等前列腺素类似物联合,已在欧洲多个中心用于药物流产。在妊娠9周前使用,这些药物与手术流产有相似的疗效。此外,在无保护性交后5天内服用孕激素拮抗剂似乎对预防妊娠有效。抗孕激素药物目前在澳大利亚无法获得。引入孕激素受体拮抗剂和现代前列腺素每年可为澳大利亚卫生预算节省约1000万美元。此外,引入用于紧急避孕的孕激素受体拮抗剂对澳大利亚女性来说在经济和情感方面的节省会更大。在澳大利亚,当已知的致癌物都可以在柜台购买时,澳大利亚人确实是时候考虑在柜台购买有效的紧急避孕药了。